You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 30, 2025

MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Magnesium Sulfate In Dextrose 5% In Plastic Container patents expire, and what generic alternatives are available?

Magnesium Sulfate In Dextrose 5% In Plastic Container is a drug marketed by B Braun Medical Inc, Baxter Hlthcare Corp, Fresenius Kabi Usa, Hospira, Hq Spclt Pharma, and Norvium Bioscience. and is included in six NDAs.

The generic ingredient in MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER is magnesium sulfate. There are one hundred and forty-six drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the magnesium sulfate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Magnesium Sulfate In Dextrose 5% In Plastic Container

A generic version of MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER was approved as magnesium sulfate by FRESENIUS KABI USA on September 8th, 1986.

  Try for Free

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER?
  • What are the global sales for MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER?
  • What is Average Wholesale Price for MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER?
Summary for MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER
Drug patent expirations by year for MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER
Recent Clinical Trials for MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of OklahomaEarly Phase 1
Daewoong Pharmaceutical Co. LTD.Phase 3
Cairo UniversityPhase 1/Phase 2

See all MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER clinical trials

US Patents and Regulatory Information for MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Exclusivity Expiration
Hospira MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER magnesium sulfate INJECTABLE;INJECTION 020488-001 Jul 11, 1995 AP RX Yes Yes ⤷  Try for Free ⤷  Try for Free ⤷  Try for Free
B Braun Medical Inc MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER magnesium sulfate INJECTABLE;INJECTION 207966-001 Oct 27, 2020 AP RX No No ⤷  Try for Free ⤷  Try for Free ⤷  Try for Free
Norvium Bioscience MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER magnesium sulfate INJECTABLE;INJECTION 209932-001 Sep 10, 2018 AP RX No No ⤷  Try for Free ⤷  Try for Free ⤷  Try for Free
Baxter Hlthcare Corp MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER magnesium sulfate INJECTABLE;INJECTION 211965-001 Aug 11, 2020 AP RX No No ⤷  Try for Free ⤷  Try for Free ⤷  Try for Free
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Exclusivity Expiration
Showing 1 to 4 of 4 entries

Market Dynamics and Financial Trajectory for Magnesium Sulfate in 5% Dextrose

Global Market Overview

The global magnesium sulfate market, which includes the formulation of magnesium sulfate in 5% dextrose, is poised for significant growth. As of 2023, the global magnesium sulfate market size was valued at USD 980.4 million, and it is projected to grow to USD 1,583.9 million by 2032, at a Compound Annual Growth Rate (CAGR) of 5.5% during the 2024-2032 period[1].

Key Drivers of Market Growth

Surging Demand from the Agriculture Industry

The increasing global population and the subsequent need for higher agricultural output are driving the demand for magnesium sulfate. Farmers rely heavily on magnesium-rich soil to ensure optimal crop growth, particularly for cash crops and vegetables. This demand is further amplified by the use of magnesium sulfate in plant nurseries for the efficient growth of potted plants[1].

Pharmaceutical Applications

Magnesium sulfate in 5% dextrose is widely used in the pharmaceutical sector, particularly for the prevention and control of seizures in pre-eclampsia and eclampsia. Its versatile nature also makes it an analgesic for migraines and a treatment for various other medical conditions. This diverse range of applications contributes significantly to market growth[1][4].

Food & Beverage Sector

The increasing preference for processed food products, driven by changing lifestyle and dietary habits, is another factor fueling the demand for magnesium sulfate. It is used as an ingredient in various food products, contributing to the overall market expansion[1].

Personal Care and Cosmetics

The rising trend of personal grooming and the high demand for cosmetic products, especially among the female population, are driving the consumption of magnesium sulfate in personal care applications. This segment is expected to continue supporting market growth[1].

Regional Market Analysis

Asia Pacific

The Asia Pacific region dominated the magnesium sulfate market in 2023, with a market share of 41.1%. Countries like China, India, and Japan are key contributors to this dominance due to their extensive industrialization and urbanization activities. China, in particular, is a significant manufacturing hub for various end-use industries such as dyes, textiles, and paints, which further supports the regional market growth[1].

Europe and North America

In Europe, the market is driven by the expansion of the chemical industry, increased spending on personal care products, and technological advancements in agriculture. In North America, factors such as rising consumer spending capacity and increasing awareness towards self-care and personal care are fueling the product demand. Additionally, investments in improving water treatment facilities are boosting the demand for magnesium sulfate[1].

South America and Middle East & Africa

In South America, increasing private and government investments in healthcare and pharmaceutical infrastructure are creating a positive environment for market growth. In the Middle East & Africa, the growing population and changing lifestyle of consumers, along with investments in the agriculture sector, are surging the product demand[1].

Challenges and Restraints

Volatility of Prices

The fluctuation in energy prices and raw material costs has led to volatility in the prices of magnesium sulfate, which is a major factor restraining market growth. The reduction in the availability of high-quality minerals further influences the prices of raw materials[1].

Adverse Health Effects

The adverse effects of magnesium sulfate-based drugs on human health, such as hives, diarrhea, difficulty in breathing, and swelling of the throat, face, or tongue, are also hindering market growth. Additionally, the intake of magnesium sulfate can affect the absorption of antibiotics by the human body[1].

Financial Trajectory

The financial trajectory of the magnesium sulfate market is promising, with a projected growth from USD 1,034.0 million in 2024 to USD 1,583.9 million by 2032. This growth is driven by the increasing demand from various sectors, including agriculture, pharmaceuticals, food & beverage, and personal care.

Segmentation and Major Applications

Fertilizer Segment

The fertilizer segment holds the major share of the magnesium sulfate market due to the rising consumption by the agriculture industry. This segment's growth is linked to the growing population, rising disposable income, and changing dietary habits[1].

Pharmaceutical Segment

The pharmaceutical segment is another significant contributor, with magnesium sulfate being used to prevent and control seizures in pre-eclampsia and eclampsia, and as an analgesic for migraines[1][4].

Adoption of Sustainable Practices

The adoption of sustainable practices is expected to offer growth opportunities to key players in the market. As companies focus on reducing their environmental footprint, the demand for magnesium sulfate, which is used in various sustainable applications, is likely to increase[1].

Product Specifications and Safety Considerations

Magnesium sulfate in 5% dextrose injection is a sterile, nonpyrogenic solution available in flexible plastic containers. It is indicated for the prevention and control of seizures in pre-eclampsia and eclampsia. However, it has several contraindications and precautions, including the risk of magnesium toxicity, fetal-neonatal toxicity with prolonged use, and exacerbation of myasthenia gravis[2][3][4].

Key Takeaways

  • The global magnesium sulfate market is projected to grow significantly, driven by demand from agriculture, pharmaceuticals, and other sectors.
  • Asia Pacific dominates the market, with China, India, and Japan being key contributors.
  • Volatility in prices and adverse health effects are major restraints on market growth.
  • The adoption of sustainable practices offers growth opportunities for key players.
  • The product has various applications, including as a fertilizer, in pharmaceuticals, and in personal care.

Frequently Asked Questions (FAQs)

Q: What are the primary applications of magnesium sulfate in 5% dextrose? A: The primary applications include the prevention and control of seizures in pre-eclampsia and eclampsia, as well as uses in agriculture as a fertilizer, in the food & beverage sector, and in personal care products[1][4].

Q: Which region dominates the magnesium sulfate market? A: The Asia Pacific region dominates the magnesium sulfate market, accounting for 41.1% of the market share in 2023[1].

Q: What are the major factors restraining the growth of the magnesium sulfate market? A: The major factors include the volatility in prices due to energy and raw material costs, and the adverse effects of magnesium sulfate-based drugs on human health[1].

Q: How is the adoption of sustainable practices impacting the market? A: The adoption of sustainable practices is expected to offer growth opportunities to key players in the market as companies focus on reducing their environmental footprint[1].

Q: What are the safety considerations for magnesium sulfate in 5% dextrose injection? A: Safety considerations include the risk of magnesium toxicity, fetal-neonatal toxicity with prolonged use, and exacerbation of myasthenia gravis. It should be administered judiciously and under medical supervision[2][3][4].

Cited Sources:

  1. Fortune Business Insights, "Magnesium Sulfate Market Size, Share & Growth | Report [2032]"
  2. FDA, "MAGNESIUM SULFATE IN 5% DEXTROSE INJECTION, USP"
  3. Baxter Healthcare Corporation, "MAGNESIUM SULFATE IN 5% DEXTROSE INJECTION, USP"
  4. B. Braun, "Magnesium Sulfate in 5% Dextrose, 1 g/100 mL"

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.